Evidence map›Paper›PMID 29467447›Full record

ArticleMucosal immunology2018

Notch signaling represents an important checkpoint between follicular T-helper and canonical T-helper 2 cell fate.

Mark Dell'Aringa, R Lee Reinhardt

Abstract read
In one paragraph

Article in Mucosal immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. GCNT1-MediatedJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mark Dell'AringaDepartment of Biomedical Research, National Jewish Health, Denver, CO, 80206, USA.
R Lee ReinhardtDepartment of Biomedical Research, National Jewish Health, Denver, CO, 80206, USA. ReinhardtL@NJHealth.org.

Funding

Basic Immunology Training ProgramT32AI052077 · NIAID · DUKE UNIVERSITY · PI KRANGEL, MICHAEL S · 2002 to 2024
$4.2M
The Role of BATF in Allergic Inflammation and Anti-Helminth ImmunityR01AI119004 · NIAID · NATIONAL JEWISH HEALTH · PI REINHARDT, RICHARD LEE · 2015 to 2019
$1.8M
NIAID NIH HHS R01 AI119004NIAID NIH HHS T32 AI052077
6 · The paper itself

Abstract

Type-2 immunity is regulated by two distinct CD4+ T-cell subsets. T follicular helper (Tfh) cells are required for humoral hallmarks of type-2 inflammation. T-helper type-2 (Th2) cells orchestrate type-2 inflammation in peripheral tissues, such as the lung and intestine. Given the importance of Notch signaling in the establishment of other CD4+ T-helper cell subsets, we investigated whether canonical Notch activation could differentially impact Tfh and Th2 cell fate during the induction of type-2 immunity. These studies show that Tfh cell, but not Th2 cell, generation and function is reliant on Notch signaling. While early Tfh cell specification is influenced by functional Notch ligands on classical dendritic cells, functional Notch ligands on cells other than dendritic cells, T cells, B cells, and follicular dendritic cells are sufficient to achieve full Tfh cell commitment. These findings identify Notch signaling as an early lineage-determining factor between Tfh and Th2 cell fate.

Indexed as

AnimalsCell DifferentiationCell LineageCells, CulturedDendritic CellsGerminal CenterInterleukin-4MiceMice, Inbred C57BLMice, KnockoutNippostrongylusReceptor, Notch2Signal TransductionStrongylida InfectionsTh2 CellsT-Lymphocyte SubsetsInterleukin-4MIB1 ligase, humanReceptor, Notch2Ubiquitin-Protein Ligases

Identifiers

PMID29467447
PMCPMC6030499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.